☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
BioInvent Report Results of BI-1206 + Rituximab in P- I/IIa Study for Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
January 28, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.